1,787 results on '"Hasle, Henrik"'
Search Results
2. DAHEAN: A Danish nationwide study ensuring quality assurance through real-world data for suspected hereditary anemia patients
3. Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
4. Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
5. Advanced MDS in Children
6. Children with cancer and their cardiorespiratory fitness and physical function—the long-term effects of a physical activity program during treatment: a multicenter non-randomized controlled trial
7. Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)
8. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
9. Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis
10. A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome
11. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
12. A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
13. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression
14. HNA specificity and association to HLA-DRB1 and -DQB1 in patients with autoimmune neutropenia of early childhood
15. Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome
16. Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
17. Inflammatory Biomarkers Can Differentiate Acute Lymphoblastic Leukemia with Arthropathy from Juvenile Idiopathic Arthritis Better Than Standard Blood Tests
18. European standard clinical practice – Key issues for the medical care of individuals with familial leukemia
19. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration
20. Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol
21. Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia.
22. Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome.
23. Genetic polymorphisms in IL‐2, IL‐10 and FOXP3 are associated with autoimmune neutropenia in early childhood and autoantibody specificity in a Danish cohort.
24. Patient‐ and parent‐reported diagnostic delay in children with central nervous system tumors in Denmark.
25. Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: a register-based cohort study from the SALiCCS research programme
26. Gut microbiota changes are associated with prolonged neutropenia after induction treatment of childhood acute lymphoblastic leukemia
27. Congenital Tooth Agenesis and Risk of Early-Onset Cancer
28. A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure
29. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
30. Classification of rare pediatric myeloid neoplasia—Quo vadis?
31. Childhood cancer: Survival, treatment modalities, late effects and improvements over time
32. ATMgerm line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
33. Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia
34. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients:A report from the PanCareLIFE consortium
35. Musculoskeletal misdiagnoses in pediatric patients with spinal tumors.
36. Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.
37. Early mortality in children with cancer in Denmark and Sweden: The role of social background in a setting with universal healthcare.
38. The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma.
39. Abdominal Complications During Treatment for Pediatric Acute Myeloid Leukemia
40. JMML WITH NRAS MUTATION IN ELANE ASSOCIATED SEVERE CONGENITAL NEUTROPENIA
41. GENOTYPE/PHENOTYPE ASSOCIATIONS IN 174 INDIVIDUALS WITH GERMLINE GATA2 MUTATIONS
42. RELAPSED UBTF-TD MDS TREATED WITH VENETOCLAX AND AZACITIDINE
43. MYELODYSPLASIA-RELATED CYTOGENETIC ABNORMALITES IN CHILDHOOD ACUTE MYELOID LEUKEMIA – A 20-YEAR I-BFM- AML COLLABORATIVE DATABASE STUDY
44. WHAT CAN WE DEDUCE FROM MOLECULAR CLASSIFICATION OF MYELOID NEOPLASIA FOR THERAPY IN PEDIATRICS?
45. Early Peripheral Blood Blast Clearance As a Prognostic Marker for Early Treatment Response in Pediatric Acute Myeloid Leukemia
46. Extreme Reticulocytosis After Splenectomy in a Patient With Hemoglobin Mizuho
47. Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
48. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup
49. Musculoskeletal Misdiagnoses in Pediatric Patients with Spinal Tumors
50. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.